Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 28760403

Health-related quality of life for immediate versus delayed androgen-deprivation therapy in patients with asymptomatic, non-curable prostate cancer (TROG 03.06 and VCOG PR 01-03 [TOAD]): a randomised, multicentre, non-blinded, phase 3 trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Oncol
Publication date
2017 Sep
First author
Duchesne GM

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2017 Sep;18(9):1142-1144. doi: 10.1016/S1470-2045(17)30573-9.
    note
    Source null
    related pmid
    28760402
    relationship
    Comment in
  2. citation
    Lancet Oncol. 2017 Nov;18(11):e633. doi: 10.1016/S1470-2045(17)30774-X.
    note
    Source null
    related pmid
    29208387
    relationship
    Comment in
  3. citation
    Lancet Oncol. 2017 Nov;18(11):e634. doi: 10.1016/S1470-2045(17)30775-1.
    note
    Source null
    related pmid
    29208388
    relationship
    Comment in
  4. citation
    Lancet Oncol. 2017 Nov;18(11):e635. doi: 10.1016/S1470-2045(17)30799-4.
    note
    Source null
    related pmid
    29208389
    relationship
    Comment in
  5. citation
    J Urol. 2018 Apr;199(4):892-894. doi: 10.1016/j.juro.2018.01.030.
    note
    Source null
    related pmid
    29642358
    relationship
    Comment in

Authors and identifiers

  1. name
    Duchesne GM
    type
    Author
  2. name
    Woo HH
    type
    Author
  3. name
    King M
    type
    Author
  4. name
    Bowe SJ
    type
    Author
  5. name
    Stockler MR
    type
    Author
  6. name
    Ames A
    type
    Author
  7. name
    D'Este C
    type
    Author
  8. name
    Frydenberg M
    type
    Author
  9. name
    Loblaw A
    type
    Author
  10. name
    Malone S
    type
    Author
  11. name
    Millar J
    type
    Author
  12. name
    Tai KH
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Duchesne GM
    type
    Author
  2. name
    Woo HH
    type
    Author
  3. name
    King M
    type
    Author
  4. name
    Bowe SJ
    type
    Author
  5. name
    Stockler MR
    type
    Author
  6. name
    Ames A
    type
    Author
  7. name
    D'Este C
    type
    Author
  8. name
    Frydenberg M
    type
    Author
  9. name
    Loblaw A
    type
    Author
  10. name
    Malone S
    type
    Author
  11. name
    Millar J
    type
    Author
  12. name
    Tai KH
    type
    Author
bibliography ids
  1. nci-bib-483cf37b29d8b57503659ad0
book metadata
content sha256
893240255e20dfb4bbaa34d5e42b626757e0cffc9fd21ae1346bf0629155670f
document type
citation
dois
  1. 10.1016/S1470-2045(17)30426-6
electronic publication date
display
2017 Jul 28
precision
day
year
2017
evidence scope
bibliographic_metadata_only
id
pubmed:28760403
immutable id
pubmed:28760403@893240255e20dfb4bbaa34d5e42b626757e0cffc9fd21ae1346bf0629155670f
journal
abbreviation
Lancet Oncol
issn electronic
1474-5488
issn print
1470-2045
issue
9
name
The Lancet. Oncology
nlm unique id
100957246
pages
1192-1201
volume
18
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2017 Sep;18(9):1142-1144. doi: 10.1016/S1470-2045(17)30573-9.
    note
    Source null
    related pmid
    28760402
    relationship
    Comment in
  2. citation
    Lancet Oncol. 2017 Nov;18(11):e633. doi: 10.1016/S1470-2045(17)30774-X.
    note
    Source null
    related pmid
    29208387
    relationship
    Comment in
  3. citation
    Lancet Oncol. 2017 Nov;18(11):e634. doi: 10.1016/S1470-2045(17)30775-1.
    note
    Source null
    related pmid
    29208388
    relationship
    Comment in
  4. citation
    Lancet Oncol. 2017 Nov;18(11):e635. doi: 10.1016/S1470-2045(17)30799-4.
    note
    Source null
    related pmid
    29208389
    relationship
    Comment in
  5. citation
    J Urol. 2018 Apr;199(4):892-894. doi: 10.1016/j.juro.2018.01.030.
    note
    Source null
    related pmid
    29642358
    relationship
    Comment in
outcomes validated
false
pmid
28760403
provenance
batch id
fb25b16edcb1373b70c1
provider
NCBI PubMed ESummary
record sha256
e97d5443ee9cdabe464b0416e0a08e3b83a929360e3fe03746b1f8a91d3d0df0
response sha256
182c99bf1974b58308315b66aa28d31c61e8fc31cf3de4cadb0340a4f6734c52
retrieved at
2026-09-09T23:47:28.490065+00:00
publication date
display
2017 Sep
precision
month
year
2017
publication types
  1. Clinical Trial, Phase III
  2. Comparative Study
  3. Journal Article
  4. Multicenter Study
  5. Randomized Controlled Trial
  6. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/28760403/
title
Health-related quality of life for immediate versus delayed androgen-deprivation therapy in patients with asymptomatic, non-curable prostate cancer (TROG 03.06 and VCOG PR 01-03 [TOAD]): a randomised, multicentre, non-blinded, phase 3 trial.

Preserved source evidence · Not medical advice